Kangmei Pharma | 600518 - Ebit



Kangmei Pharma reported CNY16.43M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Alaunos Therapeutics USD -7949000 715K Dec/2023
Avita Medical AUD -10272000 22.56M Dec/2024
Cspc Pharmaceutical CNY 1.51B 748.2M Mar/2025
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Genomma Lab Internacional MXN 1.03B 109.36M Jun/2025
Hypermarcas BRL 687.17M 896.39M Jun/2025
Ionis Pharmaceuticals USD 144.78M 290.78M Jun/2025
IQVIA Holdings USD 556M 187M Jun/2025
Jiangsu Hengrui CNY 2.8B 716.91M Jun/2025
Kangmei Pharma CNY 16.43M 19.69M Jun/2025
Moderna USD -817000000 146M Jun/2025
Organon & Co USD 360M 135M Jun/2025
Revvity USD 90.76M 79.15M Jun/2025
Sh Fosun Pharma CNY 691.16M 985.91M Jun/2025
Tectonic Therapeutic USD -22332000 8.34M Jun/2025
Viatris USD 185.4M 628M Jun/2025
Wuxi Apptec CNY 3.78B 568.56M Jun/2025
Xeris Pharmaceuticals USD 5.43M 3.75M Jun/2025
Zz Pientze Pharmaceu 485.72M 705.85M Jun/2025